Nigeria’s pharmaceutical sector has seen high import duties and other barriers weigh heavily on their operations, as they await the implementation of President Bola Tinubu’s executive order whose implementation is facing delays since it was signed over two months ago.
The devaluation of the n
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
